Katya Moniz
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Pollution top 2%
- Pharmaceutical and Antibiotic Environmental Impacts
Papers in
-
- Clostridium difficile and Clostridium perfringens research 1
- SARS-CoV-2 detection and testing 1
- SARS-CoV-2 and COVID-19 Research 1
-
- Gut microbiota and health 1
- Co-authors
- William P. Hanage (2 shared papers)Eric J. Alm (2 shared papers)Mathilde Poyet (2 shared papers)Edward Topp (1 shared paper)Tong Zhang (1 shared paper)James M. Tiedje (1 shared paper)Li-Guan Li (1 shared paper)Xiaole Yin (1 shared paper)
- Partner nations
- United StatesNetherlandsAustralia
In The Last Decade
Katya Moniz
2 papers receiving 1.2k citations
Katya Moniz's Hit Papers
Peers
Comparison fields: 5 of 79
- Molecular Medicine 233
- Pollution 442
- Infectious Diseases 607
- Applied Microbiology and Biotechnology 40
- General Dentistry 21
Countries citing papers authored by Katya Moniz
This map shows the geographic impact of Katya Moniz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katya Moniz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katya Moniz more than expected).
Fields of papers citing papers by Katya Moniz
This network shows the impact of papers produced by Katya Moniz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katya Moniz. The network helps show where Katya Moniz may publish in the future.
Co-authors
The 25 scholars most cited alongside Katya Moniz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 Titers in Wastewater Are Higher than Expected from Clinically Confirmed Cases Hit paper breakdown → | 2020 | 593 |
| 2 | An omics-based framework for assessing the health risk of antimicrobial resistance genes Hit paper breakdown → | 2021 | 569 |
About Katya Moniz
Katya Moniz is a scholar working on Infectious Diseases, Molecular Biology, Molecular Medicine, Radiology, Nuclear Medicine and Imaging and Organic Chemistry, having authored 2 papers that have together received 1.2k indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (1 paper), Gut microbiota and health (1 paper), Antibiotic Resistance in Bacteria (1 paper), COVID-19 diagnosis using AI (1 paper), SARS-CoV-2 detection and testing (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Molecular Medicine (233 citations), Pollution (442 citations), Infectious Diseases (607 citations), Applied Microbiology and Biotechnology (40 citations) and General Dentistry (21 citations). Katya Moniz has collaborated with scholars based in United States, Netherlands and Australia. Frequent co-authors include William P. Hanage, Eric J. Alm, Mathilde Poyet, Edward Topp, Tong Zhang, James M. Tiedje, Li-Guan Li, Xiaole Yin, Mathieu Groussin and Michael R. Gillings. Their work appears in journals such as Nature Communications and mSystems.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.